HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immunization with Leishmania infantum released proteins confers partial protection against parasite infection with a predominant Th1 specific immune response.

Abstract
In this study, protective effect and immune response elicited by protein fractions LiRic1 (>75 kDa) and LiRic2 (<37 kDa) released by Leishmania infantum promastigotes were analysed in challenged BALB/c mice. Viable parasites were quantified in spleen and isolated CD4(+) and CD8(+) T cells were stimulated for evaluation of proliferative response and cytokine production. Immunization triggered 50.4-66.9% of parasite reduction. Stimulated CD4(+) T cells from challenged animals revealed high proliferation. IL-12 and IFN-gamma were released by CD4(+) T cells whereas IL-4 and IL-10 were impaired. LiRic1 and LiRic2 immunization gave partial protection and a CD4(+) Th1 response. LiRic2 generated IL-12 by CD8(+) T cells pointing to its participation in protective response. These results encourage further research on the development of a vaccine that provides long-lasting protection against zoonotic visceral leishmaniasis.
AuthorsRicardo Rosa, Cláudia Marques, Olivia Roos Rodrigues, Gabriela M Santos-Gomes
JournalVaccine (Vaccine) Vol. 25 Issue 23 Pg. 4525-32 (Jun 06 2007) ISSN: 0264-410X [Print] Netherlands
PMID17478016 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Protozoan Proteins
  • Interleukin-12
  • Interferon-gamma
Topics
  • Animals
  • CD4-Positive T-Lymphocytes (immunology)
  • Immunization
  • Interferon-gamma (biosynthesis)
  • Interleukin-12 (biosynthesis)
  • Leishmania infantum (immunology)
  • Leishmaniasis, Visceral (immunology, prevention & control)
  • Lymphocyte Activation
  • Mice
  • Mice, Inbred BALB C
  • Protozoan Proteins (immunology)
  • Spleen (parasitology)
  • Th1 Cells (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: